PlainRecalls
FDA Drug Moderate Class II Terminated

Ibuprofen Tablets, USP 200 mg, 6 x 6500 Caplets (Capsule-Shaped Tablets) bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403 722, India, NDC 25000-117-30.

Reported: January 31, 2018 Initiated: January 9, 2018 #D-0235-2018

Product Description

Ibuprofen Tablets, USP 200 mg, 6 x 6500 Caplets (Capsule-Shaped Tablets) bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403 722, India, NDC 25000-117-30.

Reason for Recall

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Details

Recalling Firm
Marksans Pharma Inc.
Units Affected
2,853,500 Caplets
Distribution
Distributed to repackaging firms in NY who then distributed Nationwide in the USA.
Location
Hauppauge, NY

Frequently Asked Questions

What product was recalled?
Ibuprofen Tablets, USP 200 mg, 6 x 6500 Caplets (Capsule-Shaped Tablets) bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403 722, India, NDC 25000-117-30.. Recalled by Marksans Pharma Inc.. Units affected: 2,853,500 Caplets.
Why was this product recalled?
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 31, 2018. Severity: Moderate. Recall number: D-0235-2018.